Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy

被引：233
作者：
Li, Jun [1 ]
Liang, Huamin [2 ]
Liu, Jing [3 ]
Wang, Ziyuan [1 ]
机构：
[1] Jiangsu Normal Univ, Sch Life Sci, Xuzhou 221116, Jiangsu, Peoples R China
[2] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Technol Innovat, Hefei 230088, Anhui, Peoples R China
[3] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing 100084, Peoples R China
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2018年 / 546卷 / 1-2期
关键词：
PAMAM dendrimer; Drug delivery; Gene therapy; Multidrug resistance; Hybrid nanoparticles; SURFACE-ENGINEERED DENDRIMERS; SELECTIVE SIRNA DELIVERY; POLYAMIDOAMINE DENDRIMER; IN-VITRO; MULTIDRUG-RESISTANCE; TARGETED DELIVERY; ANTICANCER DRUG; CELLULAR UPTAKE; GENE-THERAPY; POLY(AMIDOAMINE) DENDRIMERS;
D O I：
10.1016/j.ijpharm.2018.05.045
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Poly (amidoamine) (PAMAM) dendrimers are well-defined, highly branched macromolecules with numerous active amine groups on the surface. Because of their unique properties, PAMAM dendrimers have steadily grown in popularity in drug delivery, gene therapy, medical imaging and diagnostic application. This review focuses on the recent developments on the application in PAMAM dendrimers as effective carriers for drug and gene (pDNA, siRNA) delivery in cancer therapy, including: a) PAMAM for anticancer drug delivery; b) PAMAM and gene therapy; c) PAMAM used in overcoming tumor multidrug resistance; d) PAMAM used for hybrid nanoparticles; and e) PAMAM linked or loaded in other nanoparticles.
引用
收藏
页码：215 / 225
页数：11
相关论文
共 137 条
[81]   Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications [J].
Menjoge, Anupa R. ;
Kannan, Rangaramanujam M. ;
Tomalia, Donald A. .
DRUG DISCOVERY TODAY, 2010, 15 (5-6) :171-185
[82]   Biomedical applications of dendrimers: a tutorial [J].
Mintzer, Meredith A. ;
Grinstaff, Mark W. .
CHEMICAL SOCIETY REVIEWS, 2011, 40 (01) :173-190
[83]   Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies [J].
Mitragotri, Samir ;
Burke, Paul A. ;
Langer, Robert .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (09) :655-672
[84]   Evaluation of dendrimer type bio-reducible polymer as a siRNA delivery carrier for cancer therapy [J].
Nam, Joung-Pyo ;
Nam, Kihoon ;
Jung, Simhyun ;
Nah, Jae-Woon ;
Kim, Sung Wan .
JOURNAL OF CONTROLLED RELEASE, 2015, 209 :179-185
[85]   Ternary complexes of folate-PEG-appended dendrimer (G4)/α-cyclodextrin conjugate, siRNA and low-molecular-weight polysaccharide sacran as a novel tumor-selective siRNA delivery system [J].
Ohyama, Ayumu ;
Higashi, Taishi ;
Motoyama, Keiichi ;
Arima, Hidetoshi .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2017, 99 :21-28
[86]   Poly(amidoamine) Dendrimers as a Pharmaceutical Excipient. Are We There yet? [J].
Otto, Daniel P. ;
de Villiers, Melgardt M. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (01) :75-83
[87]   Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery [J].
Parsian, Maryam ;
Mutlu, Pelin ;
Yalcin, Serap ;
Tezcaner, Aysen ;
Gunduz, Ufuk .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 515 (1-2) :104-113
[88]   An intestinal Trojan horse for gene delivery [J].
Peng, Haisheng ;
Wang, Chao ;
Xu, Xiaoyang ;
Yu, Chenxu ;
Wang, Qun .
NANOSCALE, 2015, 7 (10) :4354-4360
[89]   siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer [J].
Perepelyuk, Maryna ;
Shoyele, Olubunmi ;
Birbe, Ruth ;
Thangavel, Chellappagounder ;
Liu, Yi ;
Den, Robert B. ;
Snook, Adam E. ;
Lu, Bo ;
Shoyele, Sunday A. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 6 :259-268
[90]   Poly(amidoamine) polymers: soluble linear amphiphilic drug-delivery systems for genes, proteins and oligonucleotides [J].
Pettit, Marie W. ;
Griffiths, Peter ;
Ferruti, Paolo ;
Richardson, Simon C. W. .
THERAPEUTIC DELIVERY, 2011, 2 (07) :907-917
45678910111213